Watch Ticker

Alto Neuroscience Inc.

Go to Alto Neuroscience Inc. Website

$3.07

0.00 (0.00%)

Live

Previous Close

$3.07

Day Range

$0 - $0

Previous Day Range

$3.05 - $3.09

Market Cap

$82.8 million USD

Day Vol.

Previous Day Vol.

46790

Currency

USD

Primary Exchange

None

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different cli...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Bragar Eagel & Squire, P.C. - Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

Law firm Bragar Eagel & Squire reminds investors of class action lawsuits against Neogen, Alto Neuroscience, RxSight, and Replimune Group, alleging various financial misrepresentations and regulatory challenges.

Related tickers: NEOG, ANRO, RXST, REPL.

Read Full Article

Rosen Law Firm - ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO

Rosen Law Firm is notifying Alto Neuroscience investors about a securities class action lawsuit alleging false statements about the company's drug ALTO-100 and its effectiveness in treating major depressive disorder.

Related tickers: ANRO.

Read Full Article

Trending Tickers

Please sign in to view